General Information
Revision date
2021-09-09
Product name
This ‘Product Safety Data Information’ Sheet covers Pall Medical disposable filter cartridges, each employing
1.2.1 Relevant identified uses
The filters detailed above are intended for air and gas filtration and separation applications which do not soften, swell or adversely affect the filter or its materials of construction
Emergency telephone
DATA INFORMATION
Icons in SDS
Company Information
company name
pall corporation
GHS Information
Signal word
No
Section 2
Product definition
Article. These products are not classified as hazardous according to REACH Regulation 1907/2006, or European CLP/GHS Regulation 1272/2008.
Signal word
No signal word.
Hazard statements
No known significant effects or critical hazards.
Special packaging requirements
None. ____________________________________________________________________________________ SECTION 3 - Materials of Construction The filters detailed in Section 1 are comprised of the following materials: Material Name CAS Number Versapor RC hydrophobic acrylic copolymer membrane Pall proprietary information Modified acrylic copolymer housing body Supplier proprietary information These products are not known to contain BADGE, NOGE, or BFDGE. Trace additives will be present in the plastic components. There are no additional ingredients present which, within the current knowledge of the supplier, are classified and contribute to the classification of the article. There are no current SVHC substances known to be present in the finished articles above 0.1%. There are no current ROHS2 Directive (2011/65/EU) and amendment (2015/863) substances of concern (including Lead, Cadmium, Mercury, Hexavalent Chromium, Polybrominated biphenyl (PBB), Polybrominated diphenyl ether (PBDE), Bis(2-ethylhexyl) phthalate (DEHP), Benzyl Butyl Phthalate (BBP), Dibutyl phthalate (DBP) and Diisobutyl phthalate (DIBP)) known to be present in the materials employed in excess of the limits laid down, based on information from our suppliers and knowledge of substances used within Pall the manufacturing facility. Pall Medical filters do not employ natural rubber latex, or latex derivatives in their construction. Pall Medical products do not knowingly contain materials of direct animal origin i.e. animal parts, tissues, or body fluids however, to assist our customers in performing a TSE/BSE risk assessment, we are pleased to provide the following information: Certain plastics are known to contain trace levels of additive (e.g. calcium stearate) which are manufactured from tallow. Pall Medical products may utilize components in the fluid pathway which are fabricated from plastic resins containing tallow-derived additives at trace levels, but Pall does not test for them. Please be advised that bovine tallow-derived additives are not considered specified TSE/BSE risk materials according to the current revision of the U.S. Code of Federal Regulations, Title 21 of part 189.5, which defines specified risk material. Furthermore, the Committee for Proprietary Medicinal Product (CPMP)’s Note for guidance on minimizing the risk of transmitting animal spongiform encephalopathies via human and veterinary medicinal products (EMA410/01 rev 3) and Regulation (EU) 722/2012 EEC concerning medical devices manufactured using tissues of animal origin in Article 4, give specific consideration to tallow derivatives and states they are unlikely to be infectious or can be excluded due to the rigorous processing steps used during their manufacture examples of which are: • Trans-esterification or hydrolysis at not less than 200 °C for not less than 20 minutes under pressure (glycerol, fatty acids and fatty acid esters production), • Saponification with NaOH 12 M (glycerol and soap production) • Batch process: at not less than 95 °C for not less than 3 hours, • Continuous process: at not less than 140 °C, under pressure for not less than 8 minutes or equivalent, • Distillation at 200 °C. Pall continually works to assure the safety of our products with respect to potential BSE/TSE transmission by working through our supply chain to obtain information regarding the possible use of animal-based material and to confirm specific sourcing and processing details where applicable WARNING: This product may expose you to PFOA which is known in the State of California to cause cancer, birth defects or other reproductive harm. For more information go to www.P65Warnings.ca.gov. Medical products placed on the market in the State of California are not intended for ‘consumer’ sale and are for professional use, and as the result of use will be expected to be disposed of as ‘hazardous waste’ within an appropriate waste stream reflecting the contaminant present as the result of use. These articles are supplied in sealed bags and boxed and any direct contact with the materials of construction of those items is expected to be through ‘occupational exposure’, which does not require mandatory labelling of articles. In line with the ‘Questions and Answers for business’ (dated August 2017) on the labelling requirements – Q41 - this SDS convey this warning for occupational exposure. ____________________________________________________________________________________